PD-1 checkpoint inhibitor (Beijing Dongfang Baitai Biotechnology)

N/A

Report date: 2025/03/20 15:32:11

Base Information

Drug NamePD-1 checkpoint inhibitor (Beijing Dongfang Baitai Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Eastern Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Eastern Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A